2004
DOI: 10.1007/s10067-003-0775-5
|View full text |Cite
|
Sign up to set email alerts
|

Successful treatment of refractory adult-onset Still?s disease with infliximab. A prospective, non-comparative series of four patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
31
0
4

Year Published

2005
2005
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(36 citation statements)
references
References 16 publications
1
31
0
4
Order By: Relevance
“…Most patients diagnosed with AOSD recovered well and their function returned to normal. However, a consistent finding in the literature is that approximately one third of ASOD patients develop erosive Rheumatoid pattern polyarthritis [11][12][13][14][15] . This emphasises the importance of considering early AOSD diagnosis in any patient admitted with pyrexia of unknown origin with normal microbiological, autoimmune screen, body imaging, and bone marrow biopsy.…”
Section: Discussionmentioning
confidence: 70%
See 1 more Smart Citation
“…Most patients diagnosed with AOSD recovered well and their function returned to normal. However, a consistent finding in the literature is that approximately one third of ASOD patients develop erosive Rheumatoid pattern polyarthritis [11][12][13][14][15] . This emphasises the importance of considering early AOSD diagnosis in any patient admitted with pyrexia of unknown origin with normal microbiological, autoimmune screen, body imaging, and bone marrow biopsy.…”
Section: Discussionmentioning
confidence: 70%
“…Approximately 35% of patients require DMARDs such as methotrexate, azathioprine, cyclosporine, and cylclophosphamide as maintenance therapy to combat the disease [13] . There is good evidence supporting the use of biological agents (mainly anti-TNF agents such us infliximab and etanercept) especially in refractory AOSD patients [13][14][15] . Most patients diagnosed with AOSD recovered well and their function returned to normal.…”
Section: Discussionmentioning
confidence: 99%
“…[119] In a Greek case series, 4 patients refractory to high doses of corticosteroids and MTX responded favorably to treatment with inß iximab 3 mg/kg. [120] Inß iximab at a dose of 5 mg/kg was found to be effective in a patient with early AOSD who was steroid resistant and ineligible for MTX treatment. [121] In another study, after administering infliximab to a patient of AOSD with persistent proteinuria and arthritis, proteinuria was decreased and arthritis was improved.…”
Section: Treatmentmentioning
confidence: 97%
“…Прогноз благоприятный Полная ремиссия между эпизодами, которые имеют тенденцию к урежению и меньшей выраженности, чем начальные Может наблюдаться деструкция суставов, необходимо хирургическое вмешательство. Прогноз неблагоприятный ремиссию [64][65][66][67][68]. Интересно, что переход с одного ин-гибитора ФНО α на другой не так эффективен, как при РА [69].…”
Section: клиническийunclassified